A Murine Model for Enhancement of Streptococcus pneumoniae Pathogenicity upon Viral Infection and Advanced Age

Basma H Joma1,2, Nalat Siwapornchai1, Vijay K Vanguri3

  • 1Department of Molecular Biology and Microbiology, Tufts University School of Medicine, Boston, Massachusetts, USA.

Insights

Influenza A virus and aging worsen Streptococcus pneumoniae infections by impairing immune responses and promoting bacterial spread. This study reveals how coinfection drives pneumococcus from colonizer to pathogen, impacting antiviral defenses.

Area of Science:

  • Immunology
  • Microbiology
  • Pathogenesis

Background:

  • Streptococcus pneumoniae asymptomatically colonizes the nasopharynx but can cause severe disease.
  • Viral infections and aging are known risk factors for invasive pneumococcal disease.
  • Existing models did not fully replicate severe coinfection outcomes.

Purpose of the Study:

  • To investigate the impact of influenza A virus (IAV) coinfection on pneumococcal pathogenesis in young and aged mice.
  • To elucidate the mechanisms by which aging and IAV influence pneumococcal disease severity.
  • To explore the bidirectional interactions between pneumococcus, IAV, and host immunity.

Main Methods:

  • Established a multistep murine model: initial pneumococcal colonization followed by IAV inoculation.
  • Compared disease progression, bacterial burdens, and pulmonary inflammation in young and aged mice.
  • Assessed neutrophil function and interferon-alpha (IFN-α) production ex vivo.

Main Results:

  • Coinfection led to pneumococcal dispersal, inflammation, and mortality, with exacerbated disease in aged mice.
  • Aging and IAV infection impaired neutrophil bacterial killing.
  • Both aging and pneumococcal colonization reduced IFN-α production and increased IAV burden.

Conclusions:

  • IAV promotes pneumococcal pathogenicity by altering bacterial behavior and host immunity.
  • Aging exacerbates pneumococcal disease severity through enhanced inflammation and impaired immune cell function.
  • Pneumococcal infections can compromise antiviral responses, increasing viral burden.

Related Concept Videos